Iggbo raises $13M in Series A

What does Iggbo do?

Iggbo, is a healthcare tech company which aims at  bringing personalized medicine to more and more people via on-demand blood draws and medical testing. The company connects physicians, laboratory and phlebotomists for delivering high quality venipuncture service any where and at any time. This platform is the future of the professional phlebotomy. It is designed to be a total solution for the entire lab testing process. The company manages each aspect of diagnostic testing from initial blood drawing to packing and shipping samples.

How much Iggbo was funded?

The company raised $13M in Series A on June 21, 2016 from Heritage Group.

Previous funding

$3.07M on January 26, 2016

What is next for Iggbo?

Iggbo currently operates in more one hundred and twenty cities. The company plas ot use the latest funding for offering on demand blood collection services for health systems, diagnostic labs, retailers, providers and payers. Nuno Valentine, the company’s founder and CEO, said that blood is the starting point of healthcare and seventy percent of the med decisions are made by providers beginning with drawing of blood. Until now the blood diagnostics system was disconnected, fragmented, outdates and very inconvenient. This company is solving the issue by using smart phone technlogy and an on demand, flexible workforce for collecting blood diagnostics and other vital signs at any place and any time.

More about Iggbo

Iggbo was founded in 2015 by Nuno Valentine, Mark Van Roekel and Shaival Kapadia. The company brings customized medicine to everyone. The company is operating in more than one hundred and twenty cities, with a workforce of more than 8,000 blood draw professionals. The company’s on-demand platform is proving beneficial to all the healthcare departments from speciality labs to health systems to mobile diagnotics to tele medicine. The company is reinventing healthcare service delivery model with smart phone technology.  Now physicians and nurses can order lab tests easily and patient compliance improves to 98% and every sample is monitores tracked and connected.